Hypertension and Nephrology
FIDELIO DKD Results
Investigator Gerasimos Filippatos, MD summarizes the results of FIDELIO-DKD, which examined whether finerenone affected cardiovascular outcomes in patients with chronic kidney disease and T2DM.
The Hypertension Council fosters excellence in hypertension research and education in support of the AHA’s mission. Hypertension remains a world-wide public-health challenge and is a leading cause of stroke, heart disease, and the progression of chronic kidney disease. The annual Hypertension Scientific Sessions showcases timely research.
The KCVD Council works to reduce cardiovascular-related disability and death through research, communication, advocacy, and education about the kidney. Kidney disease is a major cause and consequence of cardiovascular disease. Chronic renal insufficiency can contribute to development of hypertension, vascular disease, atherosclerosis and other morbidity and mortality risk factors.